Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development.
about
Cathepsin K induces platelet dysfunction and affects cell signaling in breast cancer - molecularly distinct behavior of cathepsin K in breast cancer.Protease-activated receptors and their biological role - focused on skin inflammation.Micro-RNA analysis of renal biopsies in human lupus nephritis demonstrates up-regulated miR-422a driving reduction of kallikrein-related peptidase 4.A potent, proteolysis-resistant inhibitor of kallikrein-related peptidase 6 (KLK6) for cancer therapy, developed by combinatorial engineering
P2860
Kallikrein protease activated receptor (PAR) axis: an attractive target for drug development.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Kallikrein protease activated ...... e target for drug development.
@ast
Kallikrein protease activated ...... e target for drug development.
@en
Kallikrein protease activated receptor
@nl
type
label
Kallikrein protease activated ...... e target for drug development.
@ast
Kallikrein protease activated ...... e target for drug development.
@en
Kallikrein protease activated receptor
@nl
prefLabel
Kallikrein protease activated ...... e target for drug development.
@ast
Kallikrein protease activated ...... e target for drug development.
@en
Kallikrein protease activated receptor
@nl
P2093
P356
P1476
Kallikrein protease activated ...... e target for drug development.
@en
P2093
Beatrice Severino
Elisa Perissutti
Ferdinando Fiorino
Luiz Juliano
Vincenzo Santagada
P304
P356
10.1021/JM300407T
P407
P577
2012-06-12T00:00:00Z